Nu-Med Plus (NUMD) Receivables - Net (2023)
Nu-Med Plus (NUMD) posted Receivables - Net of $3500.0 for Q1 2023.
Nu-Med Plus (NUMD) Receivables - Net (2023) Analysis & Trends
Nu-Med Plus has reported Receivables - Net for 1 years, with the latest figure at $3500.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3,500.00 |
| Mar 31, 2023 | 3,500.00 |